Brief: Elevation Oncology On Sept 18, Got Notice From Nasdaq On Co's Failure To Satisfy A Continued Listing Rule Or Standard
20/09/2024 21:26
Sept 20 (Reuters) - Elevation Oncology Inc ELEV.O :
* ELEVATION ONCOLOGY INC - ON SEPT18, GOT NOTICE FROM NASDAQ
ON
CO'S FAILURE TO SATISFY A CONTINUED LISTING RULE OR STANDARD
Source text for Eikon: ID:n0001558370-24-012922
Further company coverage: ELEV.O
(Reuters.Briefs@thomsonreuters.com)
Recent news on Elevation Oncology
See all newsBrief: Elevation Oncology Terminates License Agreement With CSPC Megalith Biopharmaceutical
U.S. RESEARCH ROUNDUP- Crane, Ryder System, Terex
Brief: Elevation Oncology Says Concentra To Buy Elevation Oncology For $0.36 Per Share Plus CVR
Elevation Oncology Inc expected to post a loss of 19 cents a share - Earnings Preview
Brief: Elevation Oncology Inc - To Prepay Term Loan Under Loan & Security Agreement Dated July 27, 2022 - SEC Filing